Mahamaya Lifesciences (BOM:544611) Common Stock: ₹234 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544611 Mahamaya Lifesciences Ltd BOM:544611
16 GF Score
Price ₹186.00
! 4 Warning Signs
View Full Analysis

What is Mahamaya Lifesciences Common Stock?

Mahamaya Lifesciences BOM:544611 -1.06% 16 Common Stock is ₹234 Mil as of Mar. 2026. GuruFocus rates BOM:544611 with a GF Score™ of 16/100. The stock has 4 warning signs investors should review.

Mahamaya Lifesciences's quarterly common stock stayed the same from Sep. 2024 (₹178 Mil) to Mar. 2025 (₹178 Mil) but then increased from Mar. 2025 (₹178 Mil) to Mar. 2026 (₹234 Mil).

Mahamaya Lifesciences's annual common stock increased from Mar. 2024 (₹12 Mil) to Mar. 2025 (₹178 Mil) and increased from Mar. 2025 (₹178 Mil) to Mar. 2026 (₹234 Mil).

Mahamaya Lifesciences Common Stock Historical Data

* Premium members only.

The historical data trend for Mahamaya Lifesciences's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mahamaya Lifesciences Common Stock Chart

Mahamaya Lifesciences Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
12.49 12.49 12.49 177.66 234.05

Mahamaya Lifesciences Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Mar26
Common Stock Get a 7-Day Free Trial 12.49 12.49 177.66 177.66 234.05
BOM:544611
16GF Score
Mahamaya Lifesciences Ltd BOM:544611
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mahamaya Lifesciences Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of ₹234 Mil mean?
Mahamaya Lifesciences (BOM:544611) has a Common Stock of ₹234 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Mahamaya Lifesciences and its competitors.
Is Mahamaya Lifesciences' Common Stock too high?
Mahamaya Lifesciences' current Common Stock is ₹234 Mil. Overall, Mahamaya Lifesciences has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Mahamaya Lifesciences' Common Stock compare to CTVA and CF?
Mahamaya Lifesciences' Common Stock of ₹234 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for an Agriculture company?
A good Common Stock depends on the Agriculture industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Mahamaya Lifesciences and its competitors. Mahamaya Lifesciences's current Common Stock is ₹234 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mahamaya Lifesciences stock overvalued right now?
Mahamaya Lifesciences (BOM:544611) has a current Common Stock of ₹234 Mil. The current Common Stock is ₹234 Mil. Mahamaya Lifesciences' overall GF Score™ is 16/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Mahamaya Lifesciences (BOM:544611), the current Common Stock is ₹234 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mahamaya Lifesciences Business Description

Address Sohna Road, Sector-49, Unit No. 369, 370, 370A & 370B, 3rd Floor, Prime Tower-B1, Spaze ITech Park, Gurugram, HR, IND, 122018
Mahamaya Lifesciences Ltd specializes in the manufacturing of pesticide formulations and supplies bulk formulations catering to both Indian agrochemical companies as well as multinational corporations (MNCs). The company's offerings include Insecticides, Herbicides, and Fungicides. Geographically, it serves multiple Indian states including Punjab, Haryana, Rajasthan, and Uttar Pradesh, and internationally serves countries like the Dominican Republic, Turkey, Egypt, and the UAE. The company generates revenue from the sale of its pesticide formulations.
16GF Score

Get the complete analysis for BOM:544611

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹186.00
Price